Matthew Townsend
AbbVie (United States) · 35 works · 4,925 citations · h-index 19
Top works
- Microarray analysis of microRNA expression in the developing mammalian brain
- Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway
- Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers
- Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation
- Soluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway
- The role of cell-derived oligomers of Aβ in Alzheimer's disease and avenues for therapeutic intervention
- Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease
- Orally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers
- Activity-Dependent Induction of Tonic Calcineurin Activity Mediates a Rapid Developmental Downregulation of NMDA Receptor Currents
- The role of cell-derived oligomers of Aβ in Alzheimer's disease and avenues for therapeutic intervention
- Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models
- Developmental loss of miniature N -methyl- d -aspartate receptor currents in NR2A knockout mice
- Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption
- Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
- Pancortins interact with amyloid precursor protein and modulate cortical cell migration
- Oral Treatment with a γ-Secretase Inhibitor Improves Long-Term Potentiation in a Mouse Model of Alzheimer's Disease
- Developmental Depression of Glutamate Neurotransmission by Chronic Low-Level Activation of NMDA Receptors
- Retina-Driven Dephosphorylation of the NR2A Subunit Correlates with Faster NMDA Receptor Kinetics at Developing Retinocollicular Synapses
- When Will Alzheimer's Disease be Cured? A Pharmaceutical Perspective
- Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays